Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGM:STAA
NasdaqGM:STAAMedical Equipment

STAAR Surgical (STAA) Posts US$80.4 Million Annual Loss Testing Turnaround Narratives

STAAR Surgical FY 2025 earnings snapshot STAAR Surgical (STAA) has wrapped up FY 2025 with Q4 revenue of US$57.8 million and a basic EPS loss of US$0.37, keeping the focus firmly on the path back to profitability. The company has seen quarterly revenue range from US$42.6 million to US$94.7 million since the start of 2024, while basic EPS has swung between a loss of US$1.10 and a profit of US$0.20. This sets up a mixed picture on margins that investors may view as an ongoing turnaround story...
NasdaqCM:SRTA
NasdaqCM:SRTAHealthcare

Strata Critical Medical Q4 Loss Underscores Ongoing Profitability Gap Versus Bullish Narratives

Strata Critical Medical (SRTA) has reported its FY 2025 numbers, with Q4 revenue at US$66.8 million and a basic EPS loss of US$0.06. Trailing twelve month revenue came in at US$197.1 million with a full year basic EPS loss of US$0.24. Over recent quarters, the company has reported revenue in a range from US$36.1 million to US$66.8 million, while quarterly basic EPS losses have moved between US$0.04 and US$0.12. This keeps the focus on how efficiently it is converting sales into earnings. With...
NasdaqCM:UFPT
NasdaqCM:UFPTMedical Equipment

Does UFP Technologies' (UFPT) Expanded Intuitive Deal Reframe Its Medical Automation Investment Narrative?

In late February 2026, UFP Technologies, Inc. extended and expanded its manufacturing supply agreement with Intuitive Surgical through December 31, 2029, while also reporting higher fourth-quarter and full-year 2025 sales and earnings compared with the prior year. This combination of a longer-term, higher-volume partnership with a key customer and recent earnings growth adds further visibility to UFP Technologies’ medical device exposure and contracted revenue base. Next, we’ll examine how...
NasdaqGS:EYE
NasdaqGS:EYESpecialty Retail

Same Store Sales Strength Tests Profitability Concerns At National Vision Holdings (EYE)

National Vision Holdings (EYE) has put up a mixed FY 2025 scorecard so far, with Q3 revenue at US$487.3 million, basic EPS of US$0.04 and same store sales growth of 7.7%, set against a trailing twelve month loss of US$3.2 million and basic EPS of roughly US$0.04 loss. Over recent quarters the company has seen revenue range from US$451.7 million in Q2 2024 to US$510.3 million in Q1 2025. Basic EPS has moved from a Q4 2024 loss of US$0.37 per share to a Q1 2025 profit of US$0.18 per share and...
NYSE:ACEL
NYSE:ACELHospitality

Accel Entertainment (ACEL) Margin Improvement Challenges Bears Focused On Concentration Risks

Accel Entertainment (ACEL) has wrapped up FY 2025 with fourth quarter revenue of US$341.4 million and EPS of US$0.19, capping a year in which trailing twelve month revenue reached US$1.3 billion and EPS came in at US$0.61. The company has seen quarterly revenue move from US$302.2 million in Q3 2024 to US$341.4 million in Q4 2025, while quarterly EPS stepped up from US$0.06 to US$0.19 over the same stretch, setting the backdrop for investors focused on earnings growth and profit consistency...
NasdaqGS:CRWD
NasdaqGS:CRWDSoftware

CrowdStrike (CRWD) First Profitable Quarter Challenges Trailing Loss Narrative

CrowdStrike Holdings (CRWD) FY 2026 results in focus CrowdStrike Holdings (CRWD) has capped FY 2026 with fourth quarter revenue of about US$1.3 billion and basic EPS of US$0.15, alongside trailing twelve month revenue of roughly US$4.8 billion and a trailing basic EPS loss of US$0.65. The company has seen quarterly revenue move from US$1.06 billion in Q4 FY 2025 to US$1.31 billion in Q4 FY 2026, while basic EPS shifted from a loss of US$0.37 to a profit of US$0.15 over the same periods. For...
NasdaqGS:BCRX
NasdaqGS:BCRXBiotechs

A Look At BioCryst Pharmaceuticals (BCRX) Valuation After Its Profitability And Revenue Turnaround

BioCryst Pharmaceuticals (BCRX) drew fresh attention after reporting fourth quarter 2025 revenue of US$406.56 million and net income of US$245.85 million, compared with revenue of US$131.53 million and a net loss a year earlier. See our latest analysis for BioCryst Pharmaceuticals. The earnings swing to profitability has coincided with a 29.26% 1 month share price return and a 14.27% year to date share price return. However, the 5 year total shareholder return of a 37.03% decline shows longer...
NasdaqGS:CCOI
NasdaqGS:CCOITelecom

A Look At Cogent Communications Holdings (CCOI) Valuation After Recent Share Price Volatility

Event context and recent stock moves Cogent Communications Holdings (CCOI) has been drawing attention after recent share price swings, with the stock showing a 6.7% move over the past day and a 24.9% change over the past week. Those short term moves sit alongside a month decline of 6.6% and a past 3 months gain of 23.1%, while the 1 year total return stands at a 64.9% decline, giving investors mixed signals to assess. See our latest analysis for Cogent Communications Holdings. At a share...
NasdaqGM:ACNT
NasdaqGM:ACNTChemicals

Ascent Industries ACNT Persistent Losses Challenge Bullish Narratives Despite Premium Price To Sales Multiple

Ascent Industries FY 2025 earnings snapshot Ascent Industries (ACNT) closed out FY 2025 with Q4 revenue of US$18.8 million and a basic EPS loss of US$0.11, while trailing 12 month EPS stood at a loss of US$0.58 on revenue of US$74.9 million. The company has seen quarterly revenue move from US$40.7 million in Q4 FY 2024 to US$18.8 million in Q4 FY 2025, alongside basic EPS shifting from a profit of US$0.01 to a loss of US$0.11. This keeps the focus firmly on how efficiently each dollar of...
OTCPK:FTCO
OTCPK:FTCOMetals and Mining

Fortitude Gold (OTCPK:FTCO) Q3 Profit Challenges Bearish Loss Narratives

Fortitude Gold (FTCO) has reported its FY 2025 third quarter with revenue of US$4.7 million, basic EPS of US$0.0096 and net income of US$0.2 million. Trailing 12 month figures sit at US$25.4 million in revenue and a net loss of US$0.5 million with basic EPS at US$0.021. Over recent quarters in FY 2025, revenue has moved from US$6.5 million in Q1 to US$4.9 million in Q2, and EPS has shifted from US$0.0517 in Q1 to US$0.0350 in Q2. Together, these figures give a clearer sense of how the income...
NasdaqGS:WEYS
NasdaqGS:WEYSRetail Distributors

Weyco Group TTM Margin Decline Reinforces Bearish Profitability Narratives

Weyco Group (WEYS) has wrapped up FY 2025 with fourth quarter revenue of US$76.8 million and basic EPS of US$0.92, alongside net income excluding extra items of US$8.7 million, setting the tone for how the full year is being judged. Over recent quarters the company has seen revenue move from US$80.5 million and EPS of US$1.05 in Q4 2024 to US$73.1 million and US$0.70 in Q3 2025, before landing at the latest levels. This gives investors a clear view of how the top line and EPS have tracked...
NasdaqGM:EYPT
NasdaqGM:EYPTPharmaceuticals

Is It Too Late To Consider EyePoint (EYPT) After A 1‑Year Surge And DCF Upside?

If you are wondering whether EyePoint's share price still reflects fair value after a strong run, you are not alone. This article is here to help you size that up clearly. The stock last closed at US$18.00, with returns of 1.4% over 7 days, 35.4% over 30 days, 3.0% year to date, 173.6% over 1 year, a gain of around 7x over 3 years, and 72.2% over 5 years. Recent news coverage around EyePoint has focused on its position in ophthalmology and its pipeline, which has kept investor attention on...
NasdaqGS:FTRE
NasdaqGS:FTRELife Sciences

Is Fortrea Holdings (FTRE) Now An Opportunity After A 38.4% Share Price Slide?

If you are wondering whether Fortrea Holdings' current share price matches its underlying worth, you are not alone. This article will walk through what the numbers actually say about value. Over the past month the stock has seen a sharp 38.4% decline, following a relatively small 0.4% gain over the last 7 days and a 4.7% decline over the past year. This naturally raises questions about whether risk perceptions or return expectations have shifted. Recent news coverage has largely focused on...
NasdaqCM:PGY
NasdaqCM:PGYSoftware

Pagaya Technologies (PGY) Swing To Q4 Profit Tests Bearish Profitability Narratives

Pagaya Technologies (NasdaqCM:PGY) FY 2025 earnings snapshot Pagaya Technologies (NasdaqCM:PGY) has capped FY 2025 with fourth quarter revenue of US$334.8 million and basic EPS of US$0.40, alongside net income of US$33.0 million. The trailing 12 month line shows revenue of about US$1.3 billion and EPS of US$0.99. The company has seen quarterly revenue move from US$279.4 million and a basic EPS loss of US$3.20 in Q4 2024 to US$334.8 million and basic EPS of US$0.40 in Q4 2025, with net income...
TSX:BAM
TSX:BAMCapital Markets

Brookfield Asset Management (TSX:BAM) Margin Slippage Tests Bullish High‑Profitability Narrative

Brookfield Asset Management FY 2025 Results in Focus Brookfield Asset Management (TSX:BAM) has wrapped up FY 2025 with fourth quarter revenue of US$1.4 billion and basic EPS of US$0.35. This contributed to trailing twelve month revenue of US$4.8 billion and EPS of US$1.54. Over recent quarters the company’s revenue moved from US$1.1 billion in Q1 2025 to US$1.4 billion in Q4 2025. Quarterly EPS ranged between about US$0.36 and US$0.45, giving investors a clear view of steady profitability...
NYSE:BCO
NYSE:BCOCommercial Services

Brink’s (BCO) Valuation Check As Shares Pause After Strong One Year Return

Why Brink's Stock Is On Investors' Radar Brink's (BCO) shares were recently trading around $123.68, following a mixed stretch that included a 1 day decline and weaker week and month returns, even as past 3 months and 1 year performance remain positive. See our latest analysis for Brink's. Recent trading has cooled slightly, with a 7 day share price return of a 4.55% decline and a 30 day share price return of a 3.88% decline, yet the 1 year total shareholder return of 43.52% keeps Brink's...
NYSE:MEC
NYSE:MECMachinery

Mayville Engineering Company MEC TTM Loss Challenges Bullish Profitability Narratives

Mayville Engineering Company (MEC) has capped FY 2025 with fourth quarter revenue of US$134.3 million and a basic EPS loss of US$0.21, alongside trailing twelve month revenue of US$546.5 million and a TTM basic EPS loss of US$0.40. The company has seen quarterly revenue move from US$135.4 million and basic EPS of roughly breakeven in Q1 2025 to US$144.3 million and a loss of US$0.13 in Q3 2025, before settling at Q4’s US$134.3 million and US$0.21 loss per share. This sets up a results season...
NYSE:BGS
NYSE:BGSFood

B&G Foods (BGS) TTM Loss Of US$43.3 Million Tests Bullish Turnaround Narratives

B&G Foods FY 2025 Results: Weak EPS, Soft Margins Keep Profitability Under Pressure B&G Foods (BGS) has capped FY 2025 with fourth quarter revenue of US$539.6 million and a basic EPS loss of US$0.19, keeping the full year in loss-making territory. The company has seen quarterly revenue move from US$551.6 million in Q4 2024 to US$539.6 million in Q4 2025. Basic EPS shifted from a Q4 2024 loss of US$2.81 to a Q4 2025 loss of US$0.19, and trailing twelve month EPS for Q4 2025 stands at a loss of...
NasdaqGS:MGRC
NasdaqGS:MGRCTrade Distributors

Assessing McGrath RentCorp (MGRC) Valuation After Q4 2025 Growth Guidance And Dividend Increase

What the latest earnings tell you about McGrath RentCorp McGrath RentCorp (MGRC) drew fresh attention after reporting fourth quarter 2025 results with higher quarterly revenue and net income year over year, alongside 2026 revenue guidance and a higher quarterly dividend. For the fourth quarter of 2025, the company reported sales of US$213.77 million and total revenue of US$256.76 million. Net income for the quarter was US$49.83 million, with basic and diluted earnings per share from...
NasdaqCM:CXDO
NasdaqCM:CXDOIT

Crexendo (CXDO) Margin Expansion To 7.4% Puts Bullish Profitability Narrative To The Test

Crexendo (CXDO) has rounded out FY 2025 with Q4 revenue of US$18.1 million, basic EPS of US$0.04 and net income of US$1.2 million, capping a year in which trailing twelve month revenue reached US$68.2 million and EPS came in at US$0.17. The company has seen quarterly revenue move from US$16.1 million in Q1 2025 to US$18.1 million in Q4, while basic EPS ranged from US$0.04 to US$0.05 across the year. Trailing net profit margin was described as improving from 2.8% to 7.4% over the last 12...
NYSE:APH
NYSE:APHElectronic

Amphenol Deepens AI Datacenter Role With CCS Deal And Nvidia Ties

Amphenol (NYSE:APH) is expanding its AI datacenter connectivity footprint through the acquisition of CommScope's CCS division. The company is aligning its high speed connectivity solutions with Nvidia Rubin platforms and AI focused components. For investors watching AI infrastructure, Amphenol sits at an intersection between chips and the physical hardware that links them together. The stock trades at $132.75 and has returned 106.7% over the past 1 year. Over longer periods such as 3 and 5...
NasdaqCM:SSTI
NasdaqCM:SSTISoftware

SoundThinking (SSTI) Posts Q4 Loss As Margins Keep Bullish Turnaround Narratives Under Pressure

SoundThinking (SSTI) has just closed out FY 2025 with fourth quarter revenue of US$24.8 million and a basic EPS loss of US$0.22, capping a trailing twelve month run of US$104.1 million in revenue and a total EPS loss of US$0.74. Over the past year, the company has reported quarterly revenue between US$24.8 million and US$28.3 million, while quarterly basic EPS has ranged from a loss of US$0.12 to US$0.25. This sets up a results season in which investors may pay less attention to changes in...
NYSE:PSFE
NYSE:PSFEDiversified Financial

Paysafe Q4 Loss Extends Unprofitable Trend And Tests Bullish Profitability Narratives

Paysafe (PSFE) has wrapped up FY 2025 with fourth quarter revenue of US$438.4 million and a basic EPS loss of US$0.45, alongside trailing 12 month revenue of about US$1.7 billion and a basic EPS loss of US$3.14. Over recent periods, the company has seen quarterly revenue move between US$401 million and US$438.4 million, while quarterly basic EPS has ranged from a loss of US$1.52 to a loss of US$0.33. This sets up a mixed picture on profitability that investors will be weighing against the...
NYSE:BXP
NYSE:BXPOffice REITs

Adelante Exit And BXP Progress Create Mixed Signals For Investors

Adelante Capital Management has made a substantial reduction in its holdings of NYSE:BXP. BXP reports strong progress on its multi year business plan, including significant leasing activity, a major sales program, and key development milestones. These moves highlight changing institutional positioning in BXP alongside company actions to reshape its portfolio and execute on long term priorities. For you as an investor, this combination of a large shareholder cutting exposure and BXP...